Alychlo

miDiagnostics is a Belgian company focused on creating innovative, chip-based technology for self-administered blood analysis. The company is developing a new generation of disposable tests that require only small drops of blood, allowing for the detection of various biomarkers, including cells, proteins, nucleic acids, and small molecules. Their technology integrates a nanofluidic processor on a chip with a compact reader, facilitating lab-quality diagnostics from easy-to-access samples like finger-prick blood or nasal swabs. This approach enables both patients and clinicians to conduct rapid diagnostics conveniently and efficiently, regardless of location.

Lizy is a company based in Brussels, Belgium, that specializes in car leasing services through an online platform. Founded in 2018 by entrepreneurs Sam Heymans and Vincent Castus, Lizy aims to simplify the leasing process for small and medium-sized enterprises (SMEs) and professionals. The platform offers transparent all-in pricing, flexible contracts, and a selection of high-quality used cars that are readily available. By enabling clients to order vehicles online and have them delivered directly to their doorstep, Lizy seeks to provide a quick, easy, and cost-effective leasing solution.

Itineris specializes in developing and implementing UMAX, a cloud-based customer information and customer relationship management solution tailored for the utilities sector. UMAX utilizes workflow automation and artificial intelligence to facilitate comprehensive management of utility operations, encompassing functions such as revenue collection, asset management, and customer engagement. Built on the Microsoft Dynamics 365 platform and hosted in the Microsoft Azure Cloud, UMAX aims to streamline business processes for utility professionals. Since its founding in 2003, Itineris has established a strong track record in implementing its solutions across various clients, including notable organizations such as De Watergroep in Belgium, Eneco in the Netherlands, and the New York Department of Environmental Protection in the United States. The company focuses on empowering utility professionals to adapt to the evolving landscape of energy and water management.

SOPHiA GENETICS is a healthcare technology company focused on advancing data-driven medicine and enhancing life sciences research. The company has developed the SOPHiA DDM™ Platform, a cloud-based software-as-a-service solution that analyzes complex multimodal data sets and various diagnostic modalities. This platform is utilized by over 780 hospitals, laboratories, and biopharma institutions worldwide. Headquartered in Switzerland, SOPHiA GENETICS also maintains a presence in France, the United States, and Brazil, underscoring its commitment to improving healthcare outcomes through innovative technology.

SOPHiA GENETICS is a healthcare technology company focused on advancing data-driven medicine and enhancing life sciences research. The company has developed the SOPHiA DDM™ Platform, a cloud-based software-as-a-service solution that analyzes complex multimodal data sets and various diagnostic modalities. This platform is utilized by over 780 hospitals, laboratories, and biopharma institutions worldwide. Headquartered in Switzerland, SOPHiA GENETICS also maintains a presence in France, the United States, and Brazil, underscoring its commitment to improving healthcare outcomes through innovative technology.